This website is intended for healthcare professionals

Chemotherapy

Support for adult survivors of lymphoma: a literature review

The literature search was conducted between 1 November and 15 November 2020, and comprehensive searching was used to ensure that all relevant research was identified (Aveyard et al, 2016). Table 1...

Closed safety system for administration (CSSA): proposal for a new cytotoxic chemotherapy acronym

Safe compounding of chemotherapy has historically received more attention than drug administration (Santillo et al, 2018), and guidelines for nursing safety vary considerably across Europe. Depending...

A guide to Hodgkin and non-Hodgkin lymphomas: similarities and differences

There is no recent data for the UK, but in the USA the median age of patients diagnosed with HL is 39 years (American Cancer Society, 2018), with a male to female presentation of 59% to 41%...

Intravenous versus subcutaneous trastuzumab: an economic and patient perspective

Until December 2013, trastuzumab, licensed for the treatment of patients with Her2-positive early or metastatic breast cancer, was available as a powder for reconstitution before intravenous...

Complementary and alternative medicine use during chemotherapy for neuroendocrine tumours

In Western Australia, a drop-in centre within a cancer department offering complementary therapies appeared to enable coping with the diagnosis and treatment of cancer by facilitating comfort and...

Ambulatory approach to cancer care. Part 2: the role of nurses and the multidisciplinary team and safety

AC at this hospital is led by registered nurses, HCAs and a lead nurse/charge nurse. The team does not consist of advanced nurse practitioners, but the nurses are empowered to be independent in daily...

Oral loratadine in the management of G-CSF-induced bone pain: a pilot study

The primary aim of this pilot study was to ascertain if bone pain in a heterogeneous group of patients with cancer induced by G-CSFs could be alleviated or eliminated by loratadine. A secondary aim...

Why choose British Journal of Nursing?

BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.

What's included

  • Clinical expertise

  • Peer-reviewed research

  • Best practice guidance

  • CPD support

Subscriptions start:

From £13.75 GBP